Literature DB >> 19966983

Selective tract abnormality in adrenoleukodystrophy: Uncommon MRI finding.

Rohit Bhatia1, Soaham Desai, M V Padma, Manjari Tripathi, Kameshwar Prasad.   

Abstract

Entities:  

Year:  2008        PMID: 19966983      PMCID: PMC2781150          DOI: 10.4103/0972-2327.40230

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN: 0972-2327            Impact factor:   1.383


× No keyword cloud information.
A 9-year-old male child presented with progressive spastic pure motor quadriparesis of one year duration without any visual, auditory or extrapyramidal dysfunction. Mild cognitive impairment was present. His hemogram, liver, renal, thyroid and parathyroid profile, serum cortisol and serum ACTH were normal. His MRI brain revealed symmetric T2W hyperintensity along the descending tracts in the genu [Figure 1A], the posterior limb of internal capsule and along the brainstem [Figure 1B–D]. His MRI of spine was normal. Elevated levels of very long chain fatty acids (VLCFA) in serum confirmed the diagnosis of childhood cerebral X-linked adrenoleukodystrophy (ALD).
Figure 1

MRI Brain T2W images showing symmetrical hyperintensity (indicated by arrows) along the bilateral descending tracts in the internal capsule (axial image (a) and coronal image (b) and through the brain stem in the pons (c) and medulla (d), with associated brain stem atrophy

MRI Brain T2W images showing symmetrical hyperintensity (indicated by arrows) along the bilateral descending tracts in the internal capsule (axial image (a) and coronal image (b) and through the brain stem in the pons (c) and medulla (d), with associated brain stem atrophy X-linked ALD is a peroxisomal disorder that affects the white matter of the central nervous system, adrenal cortex and testes and is caused by a deficiency of a single enzyme, acyl-CoA synthesase, that prevents the breakdown of very long chain fatty acids (C > 22:0); which (VLCFA) subsequently accumulate in the tissues and plasma, thereby leading to cerebral demyelination, peripheral nerve abnormalities and adrenocortical and testicular insufficiency. The genetic defect responsible for X-linked ALD is located in Xq28, the terminal segment of the long arm of the X chromosome. Loes et al. described five MR imaging patterns, with their relative frequencies, ages of affected patients and patterns of progression at MR imaging.[1] The MRI in adrenoleukodystrophy classically shows the primary involvement of the deep white matter in the parieto-occipital lobes and involvement of the splenium of the corpus callosum (66% of cases are mainly found in children.), which may include the lesions of the visual and auditory pathways. The involvement of the frontal lobe or genu of the corpus callosum is observed in approximately 15.5% of cases and mainly in adolescents. Primary cerebellar white matter or combined involvement of the parieto-occipital and frontal white matter has also been described. The primary involvement of the frontopontine or corticospinal projection fibers, as seen in our case, is reported in 12% of the cases, mainly in adults. However, it may also be observed with childhood cerebral ALD, as in the present case.[23]
  3 in total

1.  Involvement of the pontomedullary corticospinal tracts: a useful finding in the diagnosis of X-linked adrenoleukodystrophy.

Authors:  A J Barkovich; D M Ferriero; N Bass; R Boyer
Journal:  AJNR Am J Neuroradiol       Date:  1997-01       Impact factor: 3.825

Review 2.  Childhood X-linked adrenoleukodystrophy: clinical-pathologic overview and MR imaging manifestations at initial evaluation and follow-up.

Authors:  Ji Hyung Kim; Hyon J Kim
Journal:  Radiographics       Date:  2005 May-Jun       Impact factor: 5.333

3.  Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy.

Authors:  D J Loes; A Fatemi; E R Melhem; N Gupte; L Bezman; H W Moser; G V Raymond
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

  3 in total
  1 in total

1.  Childhood cerebral X-linked adrenoleukodystrophy with atypical neuroimaging abnormalities and a novel mutation.

Authors:  M Muranjan; S Karande; S Sankhe; S Eichler
Journal:  J Postgrad Med       Date:  2018 Jan-Mar       Impact factor: 1.476

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.